The effect of Kineret® on brain biomarkers in patients with subarachnoid haemorrhage
- Registry ID
- EUCTR2007-005836-98
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE1
- Sponsor
- Salford Royal Foundation Trust
- Start date
- 2009-02-11
- Completion date
- 2010-07-01
- Last update
- 2026-08-16
Conditions
Summary
To determine whether intravenously administered Kineret causes a decrease in the concentration of central inflammatory biomarkers following subarchnoid haemorrhage compared to placebo
Locations
View on source registry